HDFC Pharma and Healthcare Fund vs UTI Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
Overview
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Fund | HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1967 Cr | ₹1125 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 04 Oct 2023 | 30 Jul 2005 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare Index | BSE Healthcare |
| Turn Over | % | 28% |
| Expense Ratio | 2.14 | 2.22 |
| Manager | Dhruv Muchhal | Kamal Gada |
| ISIN Code | INF179KC1HL7 | INF789F01695 |
| Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Month | -0.57% | -1.65% |
| 6 Month | 6% | 2.97% |
| 1 Year | 4.66% | -1.2% |
| 3 Year | - | 23.45% |
| 5 Year | - | 15.98% |
SIP Return Analysis
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 6 Month | 2.21% | 0.26% |
| 1 Year | 13.74% | 8.84% |
| 3 Year | - | 21.42% |
| 5 Year | - | 18.66% |
Rolling Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Year | 27.59% | 11.65% |
| 3 Year | - | 16.53% |
| 5 Year | - | 14.78% |
Risk Management
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Standard Deviation | - | 14.3% |
| Sharp | - | 1.07% |
| Beta | - | 0.89% |
| Alpha | - | 4.1% |
Fund Managers
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Name | Dhruv Muchhal | Kamal Gada |
| Total AUM | ₹520687 Cr | ₹870 Cr |
| Funds Managed | 40 | 1 |
| HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
Market Cap
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 10.09 | 1.88 |
| Mid Cap | 30.15 | 25.05 |
| Small Cap | 33.66 | 40.4 |
| Large Cap | 26.1 | 32.67 |
Sector Allocation
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 1.71 | 1.88 |
| Basic Materials | 2.86 | - |
| Healthcare | 95.43 | - |
| Pharmaceuticals & Biotechnology | - | 75.29 |
| Healthcare Services | - | 22.4 |
| Healthcare Equipment & Supplies | - | 0.43 |
Top Comparisons
Motilal Oswal Nasdaq 100 Fund of Fund- Regular Plan Growth
3Y Returns33.88%
Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option
3Y Returns12.36%
DSP Equity Savings Fund - Regular Plan - Growth
3Y Returns9.86%
Edelweiss Equity Savings Fund - Regular Plan - Growth Option
3Y Returns10.73%
Kotak Large & Midcap Fund - Growth
3Y Returns18.2%
Tata Large & Mid Cap Fund- Regular Plan - Growth Option
3Y Returns11.99%
ICICI Prudential Bharat Consumption Fund - Growth Option
3Y Returns16.21%
Aditya Birla Sun Life Consumption Fund-Growth Option
3Y Returns14.05%